Copper Homeostasis and Cuproptosis As Potential Intervention Strategy in Atherosclerosis
- PMID: 40691390
- DOI: 10.1007/s12265-025-10661-8
Copper Homeostasis and Cuproptosis As Potential Intervention Strategy in Atherosclerosis
Abstract
Atherosclerosis (AS) is a vascular disorder characterized by lipid accumulation, fibrous tissue proliferation, and calcium deposition in the intima, contributing significantly to the mortality associated with cardiovascular disease, and the pathogenesis of AS is multifaceted. Recent studies have identified copper (Cu) overlap induced cuproptosis as a key mechanism underlying cellular dysfunction in AS. Cuproptosis impacts the function and survival of multiple cell types within AS lesions by several downstream pathways, and regulating cellular cuproptosis may be a very promising clinical treatment strategy. In this review, we explored the influence of key regulatory proteins and signaling pathways associated with copper homeostasis and cuproptosis in AS, and the potential regulators of cuproptosis in AS therapy, especially the endogenous metabolites, copper ionophore, Cu oxide nanoparticles and natural products, we also discuss emerging therapeutic strategies and offering insights into future developments and translational medicine or challenge by targeting cuproptosis in AS pathogenesis.
Keywords: Atherosclerosis; Copper; Cuproptosis; Endogenous metabolites.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations: This is an original review and all data and materials in the manuscript have not been published in other journals or media. Ethics Approvale: Not applicable. Patient Consent for Publication: Not applicable. Competing Interests: All authors have declared that there are no competing interests.
References
-
- Libby P. The changing landscape of atherosclerosis. Nature. 2021;592:524–33. https://doi.org/10.1038/s41586-021-03392-8 . - DOI - PubMed
-
- Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–25. https://doi.org/10.1038/nature10146 . - DOI - PubMed
-
- Su W, Zhao Y, Wei Y, Zhang X, Ji J, Yang S. Exploring the pathogenesis of psoriasis complicated with atherosclerosis via microarray data analysis. Front Immunol. 2021;12:667690. https://doi.org/10.3389/fimmu.2021.667690 . - DOI - PubMed - PMC
-
- De Meyer G, Zurek M, Puylaert P, Martinet W. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets. Nat Rev Cardiol. 2024;21:312–25. https://doi.org/10.1038/s41569-023-00957-0 . - DOI - PubMed
-
- Tawakol A, Abohashem S, Zureigat H. Imaging apoptosis in atherosclerosis: from cell death, a ray of light. J Am Coll Cardiol. 2020;76:1875–7. https://doi.org/10.1016/j.jacc.2020.09.010 . - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- GJJ180809/the department of education in the Jiangxi province
- No. XN202025/the open funds of Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University
- XN202405/the open funds of Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University
- GZ2024YLJ128/The Ganzhou Municipal Science and Technology Project
LinkOut - more resources
Full Text Sources
Medical
Research Materials
